Skip to main content
. 2020 Jul 9;11(18):5318–5328. doi: 10.7150/jca.36636

Table 1.

Association of AGAP2-AS1 expression with clinicopathological variables in EOC patients

Variable Low AGAP2-AS1 High AGAP2-AS1 P
Expression, n (%) Expression, n (%)
n=40 n=40
Age (years)
<50 13 12 0.809
≥50 27 28
Histological subtype
Serous 39 28 0.001
Other 1 12
FIGO stage
I-II 7 15 0.045
III-IV 33 25
Histological grade
High 39 31 0.007
Low 1 9
Residual tumor diameter (cm) 0.396
<1 36 38
≥1 4 2
Lymph node metastasis
Absent 20 29 0.039
Present 20 11
CA125 level (U/ml)
<600 18 20 0.654
≥600 22 20
Ascites
<100 21 24 0.499
≥100 19 16

NOTE: The median value of AGAP2-AS1 expression was used as a cut-off for the low/high AGAP2-AS1 expression groups.